SCHEMBL19027150

SCHEMBL19027150

O=CNc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOCC(F)(F)F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.60
▸ ERBB2 P04626 5/20 0.60
▸ FBP1 P09467 2/20 0.55
▸ HDAC3 O15379 2/20 0.54
▸ HDAC4 P56524 2/20 0.54
▸ HDAC1 Q13547 2/20 0.54
▸ HDAC7 Q8WUI4 2/20 0.54
▸ HDAC2 Q92769 2/20 0.54
▸ HDAC10 Q969S8 2/20 0.54
▸ HDAC11 Q96DB2 2/20 0.54
▸ HDAC8 Q9BY41 2/20 0.54
▸ HDAC6 Q9UBN7 2/20 0.54
▸ HDAC9 Q9UKV0 2/20 0.54
▸ HDAC5 Q9UQL6 2/20 0.54
▸ KDR P35968 2/20 0.54
▸ AURKA O14965 1/20 0.54
▸ INSR P06213 1/20 0.54
▸ PDGFRB P09619 1/20 0.54
▸ FLT4 P35916 1/20 0.54
▸ CLK1 P49759 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19026693 0.90 EGFR (0.74) EGFRERBB2FBP1HDAC3HDAC4
SCHEMBL19027000 0.89 EGFR (0.58) EGFRERBB2FBP1KDR
SCHEMBL19125553 0.88 EGFR (0.63) EGFRERBB2FBP1HDAC3HDAC4
SCHEMBL17538524 0.85 FBP1 (0.59) EGFRERBB2FBP1KDRAURKA
SCHEMBL18632967 0.85 FBP1 (0.76) EGFRERBB2FBP1KDRAURKA
SCHEMBL17538523 0.83 EGFR (0.58) EGFRERBB2FBP1KDRAURKA
SCHEMBL18862875 0.83 EGFR (0.75) EGFRERBB2FBP1HDAC3HDAC4
SCHEMBL17538486 0.82 EGFR (0.85) EGFRERBB2
SCHEMBL21761244 0.82 EGFR (0.63) EGFRERBB2FBP1KDRAURKA
SCHEMBL18862786 0.80 EGFR (0.77) EGFRERBB2KDRPDGFRBFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181553-A1 QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Arromax Pharmatech Co., Ltd. (CN) 2017-06-21 — — EP disclosed
Send feedback